Remco G A Erkens

Years Active: 2023-2023
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Remco G A Erkens, Jorg J A Calis, Anouk Verwoerd, Sytze De Roock, Nienke M Ter Haar, Gerda Den Engelsman, Lars T Van der Veken, Robert F Ernst, Hanneke W M Van Deutekom, Alex Pickering, Rianne C Scholman, Marc H A Jansen, Joost F Swart, Rashmi Sinha, Johannes Roth, Grant S Schulert, Alexei A Grom, Jorg Van Loosdregt, Sebastiaan J Vastert
Recombinant Interleukin-1 Receptor antagonist is an effective first-line treatment strategy in new-onset systemic Juvenile Idiopathic Arthritis, irrespective of HLA-DRB1 background and IL1RN variants. Arthritis & rheumatology (Hoboken, N.J.) (2023)

Remco G A Erkens.css-eqlu8i{font-size:small;padding-left:4px;}